These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 20962093)
1. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Ni Z; Knorr DA; Clouser CL; Hexum MK; Southern P; Mansky LM; Park IH; Kaufman DS J Virol; 2011 Jan; 85(1):43-50. PubMed ID: 20962093 [TBL] [Abstract][Full Text] [Related]
2. Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo. Ni Z; Knorr DA; Bendzick L; Allred J; Kaufman DS Stem Cells; 2014 Apr; 32(4):1021-31. PubMed ID: 24307574 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039 [TBL] [Abstract][Full Text] [Related]
4. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. Fogli M; Mavilio D; Brunetta E; Varchetta S; Ata K; Roby G; Kovacs C; Follmann D; Pende D; Ward J; Barker E; Marcenaro E; Moretta A; Fauci AS PLoS Pathog; 2008 Jul; 4(7):e1000101. PubMed ID: 18617991 [TBL] [Abstract][Full Text] [Related]
5. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation. Gooneratne SL; Center RJ; Kent SJ; Parsons MS Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083 [TBL] [Abstract][Full Text] [Related]
6. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050 [TBL] [Abstract][Full Text] [Related]
7. Preparation and use of HIV-1 infected primary CD4+ T-cells as target cells in natural killer cell cytotoxic assays. Davis ZB; Ward JP; Barker E J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445040 [TBL] [Abstract][Full Text] [Related]
8. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036 [TBL] [Abstract][Full Text] [Related]
9. Differential role of natural killer group 2D in recognition and cytotoxicity of hepatocyte-like cells derived from embryonic stem cells and induced pluripotent stem cells. Cisneros T; Dillard DW; Qu X; Arredondo-Guerrero J; Castro M; Schaffert S; Martin R; Esquivel CO; Krams SM; Martinez OM Am J Transplant; 2019 Jun; 19(6):1652-1662. PubMed ID: 30549427 [TBL] [Abstract][Full Text] [Related]
10. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation. Tomescu C; Tebas P; Montaner LJ AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449 [TBL] [Abstract][Full Text] [Related]
11. Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. Bernstein HB; Kinter AL; Jackson R; Fauci AS AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1189-95. PubMed ID: 15588341 [TBL] [Abstract][Full Text] [Related]
12. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals. Ahmad A; Menezes J AIDS; 1996 Feb; 10(2):143-9. PubMed ID: 8838701 [TBL] [Abstract][Full Text] [Related]
13. Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils. Smalls-Mantey A; Connors M; Sattentau QJ PLoS One; 2013; 8(9):e74858. PubMed ID: 24040353 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15. Loubeau M; Ahmad A; Toma E; Menezes J J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564 [TBL] [Abstract][Full Text] [Related]
15. Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection. Ziegner U; Campbell D; Weinhold K; Frank I; Rutstein R; Starr SE Clin Diagn Lab Immunol; 1999 Sep; 6(5):718-24. PubMed ID: 10473524 [TBL] [Abstract][Full Text] [Related]
16. NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells. Tomescu C; Chehimi J; Maino VC; Montaner LJ J Immunol; 2007 Aug; 179(4):2097-104. PubMed ID: 17675468 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication. He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576 [TBL] [Abstract][Full Text] [Related]
19. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis. Tasca S; Tambussi G; Nozza S; Capiluppi B; Zocchi MR; Soldini L; Veglia F; Poli G; Lazzarin A; Fortis C AIDS; 2003 Nov; 17(16):2291-8. PubMed ID: 14571180 [TBL] [Abstract][Full Text] [Related]
20. NK Cells in HIV Disease. Scully E; Alter G Curr HIV/AIDS Rep; 2016 Apr; 13(2):85-94. PubMed ID: 27002078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]